News
Market
Jobs
About
Contact
List Product
Register
Login
Generate
WhatsApp Message
*COVID-19 Vaccine: US Drugmaker Pfizer Now Expects US$33.5 Billion Revenue* *Follow Pindula on WhatsApp for daily new updates* https://whatsapp.com/channel/0029Va84dngJP21B2nWeyM3v?rv Pfizer, a US drugmaker Wednesday sharply increased its 2021 projection for revenues tied to its COVID-19 vaccine forecasting generating US$33.5-billion in sales instead of US$26-billion predicted in May. The company which has partnered with Germany’s BioNTech on the vaccine is estimating to deliver 2.1 billion doses. ---------- *HOT DEALS:* *itel A70 - (128GB, 3GB RAM) $89,* *itel A70 - (256GB, 4GB RAM) $99* *itel P40 (128GB, 4GB), (6000mAh) $99* *itel P40 (64GB, 4G), (6000mAh) $93* *LATEST: itel S24 (128) $124; S24 (256GB) $159* Cash on Delivery in Harare & Bulawayo. Tinotumira kwamuri inosvika. WhatsApp: 0️⃣7️⃣8️⃣3️⃣ 4️⃣5️⃣0️⃣ 7️⃣9️⃣3️⃣ ---------- Pfizer Chief Executive Albert Bourla said more than a billion doses of the vaccine have been delivered, saying “the speed and efficiency of our efforts with BioNTech to help vaccinate the world against COVID-19 have been unprecedented.” Pfizer said the pre-tax profit margin on the COVID-19 vaccine sales was in the “high-20s” in terms of per cent, the same as the earlier forecast. The drugmaker reported second-quarter profits of $5.6-billion, up 59 per cent from the year-ago period on a 92 per cent increase in revenues to $19 billion. Pfizer pushes for a third shot as Delta drives global outbreaks Pfizer/BioNTech To Produce COVID-19 Vaccine In South Africa COVID-19 Vaccine: 23 Die Within Days Of Receiving Pfizer COVID-19 Vaccines Do Not Harm Sperm Count – Study Local Health Expert Explains Norwegian COVID-19 Vaccine Deaths Pfizer has launched clinical studies on a possible third dose of the COVID-19 vaccine as a booster shot. Bourla has said such boosters could amount to a “durable” revenue stream for the company. US health officials have thus far not far backed a third shot for the broad population, but officials are studying the need for a third shot in immunocompromised people. More: AFP _If you found this article useful_ *Please support Pindula by forwarding to friends and groups*
Copy to clipboard
Give us Feedback
Full Name
WhatsApp Number
Feedback
Submit
Feedback